Drugplain

Bijuva 1 mg/1

estradiol and progesterone · CAPSULE · Mayne Pharma LLC

No Recall HistoryCurrently in Shortage
Plain English

Bijuva is a capsule containing estradiol and progesterone at 1 mg/1, taken oral. Manufactured by Mayne Pharma LLC.

Key Facts

Brand Name
Bijuva
Generic Name
estradiol and progesterone
NDC Code (Product)
50261-211
Manufacturer
Mayne Pharma LLC
Strength
1 mg/1
Dosage Form
CAPSULE
Route
ORAL
Marketing Status
Application #
NDA210132
Drug Class
Estrogen [EPC]; Progesterone [EPC]
Marketing Start
04/03/2019

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use64 reports
drug ineffective62 reports
headache55 reports
vaginal haemorrhage52 reports
dizziness40 reports
hot flush39 reports
breast tenderness36 reports
nausea32 reports
weight increased25 reports
fatigue23 reports

Frequently Asked Questions

What is Bijuva used for?

Bijuva contains estradiol and progesterone. It is a capsule taken oral. Consult your doctor for specific uses.

Is Bijuva a controlled substance?

Bijuva is not classified as a controlled substance by the DEA.

What is the generic name for Bijuva?

The generic name for Bijuva is estradiol and progesterone. There are no other listed brand versions of estradiol and progesterone.

What is the NDC code for Bijuva 1 mg/1?

The NDC (National Drug Code) for Bijuva 1 mg/1 is 50261-211, listed by Mayne Pharma LLC.

Product NDC

50261-211

Package NDC

50261-211-05

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)